logo
welcome
Reuters

Reuters

Vertex Pharma lifts annual revenue forecast on cystic fibrosis treatments strength

Reuters
Summary
Nutrition label

82% Informative

Vertex Pharmaceuticals raised its annual revenue forecast after beating third-quarter estimates.

Cystic fibrosis is a genetic disorder that affects the lungs, digestive system and other organs.

Vertex 's top-selling CF drug Trikafta rose more than 13% to $2.59 billion for the quarter ended Sept. 30 .

VR Score

92

Informative language

98

Neutral language

72

Article tone

formal

Language

English

Language complexity

59

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links